Handbook of Incretin-based Therapies in Type 2 Diabetes by Stephen Gough

By Stephen Gough

This concise instruction manual offers an outline of incretin-based treatments and counsel for incorporating them into the remedy of variety 2 diabetes. Chapters contain landmark scientific trials and overseas therapy guidance so one can replace readers with all significant advances within the box. a fantastic source for doctors that deal with sufferers with kind 2 diabetes in medical institution and medical settings.

Show description

Read or Download Handbook of Incretin-based Therapies in Type 2 Diabetes PDF

Best endocrinology & metabolism books

Advances in Research and Applications: Steroids

Steroids is a thematic quantity from the vintage educational Press sequence, supplementations and Hormones . Gerald Litwack, the hot editor of this prestigious serial, brings jointly prime individuals to the research of steroids. those structurally and functionally advanced molecules are of curiosity to a large cross-section of endocrinologist, mobile biologists, and biochemists.

Endocrinologie de l’adolescent: Tome 2 Orientations diagnostiques : Les spécificités de l’adolescence

Los angeles prise en cost médicale d’un adolescent revêt un caractère spécifique, elle doit être adaptée � un corps en croissance et en développement, bouleversé par des changements psychologiques, physiques et environnementaux, par sa relation � son corps, � sa maladie, au corps médical and so on. L’endocrinologie, en particulier, doit s’adapter pour accompagner l. a. croissance et los angeles puberté des teens atteints d’une pathologie endocrinienne aiguë ou chronique.

Cytopathology of Liver, Biliary Tract, Kidney and Adrenal Gland

This quantity fulfills the necessity for an easy-to-use and authoritative synopsis of intra-abdominal organ cytopathology. a part of the necessities in Cytopathology e-book sequence, the publication is seriously illustrated with a whole colour artwork software, whereas the textual content follows a undemanding define structure. The booklet additionally suits into the lab coat pocket and is perfect for portability and speedy reference.

Exercise and Chronic Disease: An Evidence-Based Approach

It truly is now largely permitted that there are very important hyperlinks among state of being inactive and lifestyle-related continual illnesses, and that workout can carry tangible healing advantages to individuals with long term persistent stipulations. workout and persistent ailment: An Evidence-Based procedure deals the main updated survey at present to be had of the medical and scientific facts underlying the consequences of workout on the subject of sensible results, disease-specific health-related results and caliber of lifestyles in sufferers with continual sickness stipulations.

Extra resources for Handbook of Incretin-based Therapies in Type 2 Diabetes

Sample text

The fusion to albumin and the amino acid substitution both result in a longer half-life and, thus, the need for less-frequent dosing. Albiglutide has a molecular weight of approximately 70,000 g/mol. Maximum concentrations of albiglutide were reached 3–5 days after a single 30 mg subcutaneous dose. Steady-state concentrations are achieved after 4–5 weeks of once-weekly administration. The elimination half-life is approximately 5–7 days, making it suitable for once-weekly administration [21]. Albiglutide has been studied as monotherapy and add-on therapy to metformin, sulfonylureas, thiazolidinediones, insulin glargine, and 36 • HA ND B O O K O F I N C R E T IN � B A S E D T H E R AP IE S IN T YP E 2 D IA B E T E S varying combinations of these agents [22–27].

1996;271(3 Pt 1):E458-E464. 37 Holst JJ, Deacon CF. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia. 2005;48:612-615. 38 Hjøllund KR, Deacon CF, Holst JJ. Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs. Diabetologia. 2011;54:2206-2208. 39 Imeryuz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Penacarrillo ML, Ulusoy NB. Glucagonlike peptide-1 inhibits gastric emptying via vagal afferent- mediated central mechanisms.

The physiological and pharmacological actions of GLP-1 were used to develop two drug classes of incretin-based therapies: GLP-1 receptor agonists (GLP-1 RA) for injectable therapy and orally active DPP-4 inhibitors. GLP-1 RA stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner. They also have extrapancreatic effects; the most important for type 2 diabetes therapy are the slowing of gastric emptying, a stimulation of sensations of satiety and fullness by direct action on the central nervous system, and body weight reduction [1].

Download PDF sample

Rated 4.05 of 5 – based on 17 votes